Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

Janani L, Munro APS, Wright A, Aley PK, Babbage G, Baxter D, Bawa T, Bibi S, Bula M, Cathie K, Chatterjee K, Cosgrove C, Enever Y, Galiza E, Goodman AL, Green CA, Harris M, Hicks A, Jones CE, Kanji N, van der Klaauw AA, Libri V, Llewelyn MJ, Mansfield R, McGregor AC, Minassian AM, Moore P, Mujadidi YF, Belhadef HT, Holliday K, Osanlou O, Osanlou R, Pacurar M, Palfreeman A, Regan K, Saich S, Saralaya D, Sharma S, Sheridan R, Stokes M, Thomson EC, Todd S, Twelves C, Wright D, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Nguyen-Van-Tam JS, Cornelius V, Lambe T, Heath PT, Liu X, Faust SN, COV-BOOST study group

Open source

DOI: 10.1016/j.jinf.2025.106576
Published: 2025 Sep
Container: The Journal of infection
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jinf.2025.106576,
  title = {Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.},
  author = {Janani L and Munro APS and Wright A and Aley PK and Babbage G and Baxter D and Bawa T and Bibi S and Bula M and Cathie K and Chatterjee K and Cosgrove C and Enever Y and Galiza E and Goodman AL and Green CA and Harris M and Hicks A and Jones CE and Kanji N and van der Klaauw AA and Libri V and Llewelyn MJ and Mansfield R and McGregor AC and Minassian AM and Moore P and Mujadidi YF and Belhadef HT and Holliday K and Osanlou O and Osanlou R and Pacurar M and Palfreeman A and Regan K and Saich S and Saralaya D and Sharma S and Sheridan R and Stokes M and Thomson EC and Todd S and Twelves C and Wright D and Read RC and Charlton S and Hallis B and Ramsay M and Andrews N and Nguyen-Van-Tam JS and Cornelius V and Lambe T and Heath PT and Liu X and Faust SN and COV-BOOST study group},
  year = {2025},
  journal = {The Journal of infection},
  doi = {10.1016/j.jinf.2025.106576},
  url = {https://doi.org/10.1016/j.jinf.2025.106576}
}

RIS

TY  - JOUR
TI  - Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.
AU  - Janani L
AU  - Munro APS
AU  - Wright A
AU  - Aley PK
AU  - Babbage G
AU  - Baxter D
AU  - Bawa T
AU  - Bibi S
AU  - Bula M
AU  - Cathie K
AU  - Chatterjee K
AU  - Cosgrove C
AU  - Enever Y
AU  - Galiza E
AU  - Goodman AL
AU  - Green CA
AU  - Harris M
AU  - Hicks A
AU  - Jones CE
AU  - Kanji N
AU  - van der Klaauw AA
AU  - Libri V
AU  - Llewelyn MJ
AU  - Mansfield R
AU  - McGregor AC
AU  - Minassian AM
AU  - Moore P
AU  - Mujadidi YF
AU  - Belhadef HT
AU  - Holliday K
AU  - Osanlou O
AU  - Osanlou R
AU  - Pacurar M
AU  - Palfreeman A
AU  - Regan K
AU  - Saich S
AU  - Saralaya D
AU  - Sharma S
AU  - Sheridan R
AU  - Stokes M
AU  - Thomson EC
AU  - Todd S
AU  - Twelves C
AU  - Wright D
AU  - Read RC
AU  - Charlton S
AU  - Hallis B
AU  - Ramsay M
AU  - Andrews N
AU  - Nguyen-Van-Tam JS
AU  - Cornelius V
AU  - Lambe T
AU  - Heath PT
AU  - Liu X
AU  - Faust SN
AU  - COV-BOOST study group
PY  - 2025
JO  - The Journal of infection
DO  - 10.1016/j.jinf.2025.106576
UR  - https://doi.org/10.1016/j.jinf.2025.106576
ER  -

APA

L, J., APS, M., A, W., PK, A., G, B., D, B., T, B., S, B., M, B., K, C., K, C., C, C., Y, E., E, G., AL, G., CA, G., M, H., A, H., CE, J., N, K., AA, V. D. K., V, L., MJ, L., R, M., AC, M., AM, M., P, M., YF, M., HT, B., K, H., O, O., R, O., M, P., A, P., K, R., S, S., D, S., S, S., R, S., M, S., EC, T., S, T., C, T., D, W., RC, R., S, C., B, H., M, R., N, A., JS, N., V, C., T, L., PT, H., X, L., SN, F., & group, C. S. (2025). Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.. The Journal of infection. https://doi.org/10.1016/j.jinf.2025.106576

Source records

pubmed · retrieved 2026-09-25T05:06:02.725Z
europe-pmc · retrieved 2026-09-25T05:06:02.753Z